The hospital lobby has filed a lawsuit seeking to block the federal government’s 340B Rebate Model Pilot Program, which is ...
The American Hospital Association (AHA), the Maine Hospital Association and four non-profit health systems (the Plaintiffs) ...
Hospital groups raise issues with 340B rebate pilot program citing cash flow, administrative costs, and unclear rebate denials risks.
Ten medications accounted for nearly one-third of 340B program-covered outpatient drugs in 2024, according to a Dec. 11 report.  The Health Resources and Services Administration, an HHS agency, ...
Three expert witnesses at a recent Senate HELP Committee hearing outlined weaknesses and misaligned incentives driving growth in the 340B drug pricing program.
Too many hospitals take advantage of 340B, intended to make medications affordable for low-income patients. A New York ...
At a recent Senate hearing, which refocused attention on the broken 340B Drug Pricing Program, lawmakers were reminded of how ...
Key Takeaways - CMS launches Drug Acquisition Cost Survey beginning Jan. 1, 2026. OPPS hospitals must submit NDC-level pricing data for ...
Competing policy efforts to lower drug prices could muddy the waters of drug pricing and leave patients unable to afford ...
TN's U.S. Rep. Diana Harshbarger (R-01) has introduced the 340B Access Act to ensure savings benefit everyone, including rural residents.
The American Hospital Association and several large hospital systems have filed a lawsuit seeking to halt an upcoming pilot ...
Congress must pass Rep. Diana Harshbarger's bipartisan proposal to ensure federal 340B dollars are used as intended.